Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,089 hedge funds and large institutions have $105B invested in Allergan plc in 2015 Q1 according to their latest regulatory filings, with 298 funds opening new positions, 549 increasing their positions, 185 reducing their positions, and 40 closing their positions.
645% more first-time investments, than exits
New positions opened: 298 | Existing positions closed: 40
197% more repeat investments, than reductions
Existing positions increased: 549 | Existing positions reduced: 185
63% more capital invested
Capital invested by funds: $64.6B → $105B (+$40.6B)
48% more funds holding in top 10
Funds holding in top 10: 123 → 182 (+59)
30% more funds holding
Funds holding: 840 → 1,089 (+249)
15% more call options, than puts
Call options by funds: $2.92B | Put options by funds: $2.55B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.6B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.18B |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.33B |
| 4 |
PC
Paulson & Co
New York
|
+$1.16B |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$949M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$117M |
| 2 |
SIG
Senator Investment Group
New York
|
-$92.7M |
| 3 |
EPCM
Eton Park Capital Management
New York
|
-$85.7M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$82.8M |
| 5 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$69.4M |
AGN Hedge Fund Activity: Q1 2015 in Review
1,089 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2015, worth a combined $105B — up 63% from $64.6B a quarter earlier.
Buyers outnumbered sellers: 298 funds opened new AGN positions and 40 closed out — a net gain of 258 holders — while 549 added to existing stakes and 185 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $2.6B. The largest seller was Renaissance Technologies, exiting entirely with an estimated $117M sold.
- 1,089 institutional investors held Allergan plc (AGN) as of Q1 2015, up from 840 in Q4 2014.
- Funds reported $105B of Allergan plc stock for Q1 2015, up 63% quarter-over-quarter.
- 298 funds opened new Allergan plc positions in Q1 2015 and 40 closed out, a net change of +258 holders.
- The largest Allergan plc buyer in Q1 2015 was T. Rowe Price Associates, an estimated $2.6B added.
- The largest Allergan plc seller in Q1 2015 was Renaissance Technologies, an estimated $117M sold.
Based on aggregated 13F filings for Q1 2015.